Literature DB >> 9363236

Insulin-like growth factor-I as a local regulator of proliferation and differentiated function of the human trophoblast in early pregnancy.

T Maruo1, K Murata, H Matsuo, T Samoto, M Mochizuki.   

Abstract

In order to elucidate the role of insulin-like growth factor-I (IGF-I) in human placental growth and function, the effects of IGF-I on the proliferation and differentiation of trophoblasts were investigated using an organ culture system of early placental tissues. Explants of trophoblastic tissues obtained from 4-5-week or 6-12-week placentae were, respectively, cultured with or without IGF-I, in a serum-free condition. The effect of IGF-I on the proliferative activity of trophoblasts was examined by immunocytochemical techniques with a monoclonal antibody to proliferating cell nuclear antigen (PCNA), while the effect of IGF-I on the differentiated function of trophoblasts was assessed by determining the ability to secrete human chorionic gonadotropin (hCG) and human placental lactogen (hPL). In 4-5-week placentae, IGF-I and IGF-I receptor were almost exclusively localized in cytotrophoblasts and IGF-I augmented the proliferative activity of cytotrophoblasts without affecting the ability to secrete hCG and hPL. By contrast, in 6-12-week placentae, IGF-I and IGF-I receptor were localized in both cytotrophoblasts and syncytiotrophoblasts and IGF-I stimulated the secretion of hCG and hPL following the enhancement of the proliferative activity of trophoblasts. In column chromatography of the serum-free medium obtained following 5-day culture of early placental tissues, an elution peak of immunoreactive IGF-I was found in the fractions similar to the elution region of [125I]IGF-I. These findings suggest that IGF-I acts as an autocrine/paracrine factor in regulating early placental growth and function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9363236

Source DB:  PubMed          Journal:  Early Pregnancy        ISSN: 1354-4195


  8 in total

Review 1.  Placental phenotype and the insulin-like growth factors: resource allocation to fetal growth.

Authors:  Amanda N Sferruzzi-Perri; Ionel Sandovici; Miguel Constancia; Abigail L Fowden
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

Review 2.  Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues.

Authors:  Fatemeh Hendijani
Journal:  Cell Prolif       Date:  2017-02-01       Impact factor: 6.831

3.  IGF2 actions on trophoblast in human placenta are regulated by the insulin-like growth factor 2 receptor, which can function as both a signaling and clearance receptor.

Authors:  Lynda K Harris; Ian P Crocker; Philip N Baker; John D Aplin; Melissa Westwood
Journal:  Biol Reprod       Date:  2010-10-27       Impact factor: 4.285

4.  Involvement of transcription factor NR2F2 in human trophoblast differentiation.

Authors:  Michael A Hubert; Susan L Sherritt; Cindy J Bachurski; Stuart Handwerger
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

Review 5.  Insulin and the IGF system in the human placenta of normal and diabetic pregnancies.

Authors:  Ursula Hiden; Elisabeth Glitzner; Michaele Hartmann; Gernot Desoye
Journal:  J Anat       Date:  2009-05-07       Impact factor: 2.610

Review 6.  New insights into the regulation of human cytotrophoblast cell differentiation.

Authors:  Stuart Handwerger
Journal:  Mol Cell Endocrinol       Date:  2009-12-28       Impact factor: 4.102

Review 7.  The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth.

Authors:  A N Sferruzzi-Perri; J A Owens; K G Pringle; C T Roberts
Journal:  J Physiol       Date:  2010-10-04       Impact factor: 5.182

8.  Isolation and characterization of human trophoblast side-population (SP) cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line.

Authors:  Tomoka Takao; Kazuo Asanoma; Kiyoko Kato; Kotaro Fukushima; Ryosuke Tsunematsu; Toshio Hirakawa; Sueo Matsumura; Hiroyuki Seki; Satoru Takeda; Norio Wake
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.